Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2026-01-01 @ 2:45 PM
Study NCT ID:
NCT02925403
Status:
COMPLETED
Last Update Posted:
2019-11-06
First Post:
2016-10-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant
Sponsor:
University of Oxford
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08-26
Start Date Type:
ACTUAL
Primary Completion Date:
2017-02-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02-15
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-04
First Submit QC Date:
None
Study First Post Date:
2016-10-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-07-16
Results First Submit QC Date:
None
Results First Post Date:
2019-11-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-17
Last Update Post Date:
2019-11-06
Last Update Post Date Type:
ACTUAL